IL15 and neoplasm: In neuroblastoma, GD2-specific CAR-T cells co-expressing IL-15 outperformed their IL-15-negative counterparts, exhibiting reduced exhaustion, improved in vivo persistence, complete tumor eradication, and protection upon tumor re-challenge in a metastatic xenograft model (46).